Safety and cardiometabolic efficacy of novel antidiabetic drugs.
Expert opinion on drug safety（2023）
摘要
Future avenues of research to explore include the use of novel antidiabetic agents to reduce post-myocardial infarction (MI) CV risk and arrhythmias independent of their use as diabetic agents.
更多查看译文
关键词
Cardiovascular safety,cardiovascular outcome trials,dipeptidyl dipeptidase-4 inhibitors,glucagon-like peptide-1 receptor agonists,novel antidiabetic drugs,sodium-glucose cotransporter-2 inhibitors,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要